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Absence of Evidence or Evidence of AbsenceIn their recent perspective, Arbab-Zadeh and
Fuster explore the generally accepted concept that
atherothrombotic events result from the interaction
between systemic factors (inﬂammation and throm-
bosis) and local substrates (individual plaques).
Although this notion has appeared in the literature
for more than a decade, the authors emphasize the
importance of overall atherosclerotic plaque burden
rather than identiﬁcation and characterization of
vulnerable (or high-risk) plaque in cardiovascular
(CV) risk prediction.
Fundamentally, the authors accept that “plaque
ruptures and erosions are indeed responsible for
most culprit lesions in patients with acute events”
but express reservations about the feasibility of
vulnerable plaque diagnosis, given the prevalence of
subclinical plaque rupture events. However, several
points are worth considering when evaluating the
merits of the authors arguments:
1. Imaging studies associating vulnerable plaque with
future CV events have generally not accounted
for anatomic plaque burden as a confounder.TABLE 1 Study Types and Cardiovascular Event Predictor
Plaque Burden
First Author
(Ref. #) Population Events
Budoff et al. (1) N ¼ 25,252 asymptomatic
patients undergoing CAC
All-cause death: RR ¼
CAC >1,000 and R
CAC 400–699 (bot
Cho et al. (4) N ¼ 27,125 asymptomatic
patients undergoing CTA
and CAC
All-cause death: HR ¼
for CAC >400 (p ¼
HR ¼ 2.91 for mult
(p ¼ 0.001)
Criqui et al. (3) N ¼ 3,398 asymptomatic
cohort undergoing CAC
CVD: HR ¼1.68 per SD
in CAC volume (p <
*Remained signiﬁcant after adjusting for anatomic plaque burden (CAD >50% stenosis)
ACS¼ acute coronary syndrome(s); CAC ¼ coronary artery calcium; CAD ¼ coronary art
MACE ¼major adverse cardiac event(s); MRI ¼magnetic resonance imaging; OR ¼ odds r
VH ¼ virtual histology.Similarly, studies of anatomic plaque burden have
typically not adjusted for high-risk plaque features.
Given this, and that most imaging studies account
for similar CV and demographic risk factors, it is
instructive to compare the predictive value of
selected studies comparing anatomic burden to
vulnerable plaque (Table 1). Notably, the adjusted
risk estimates for death and/or major adverse car-
diac events (MACE) are generally comparable for
both plaque burden and plaque vulnerability char-
acteristics. The study by Budoff et al. (1) represents
the exception to this trend but was assessed in the
extreme upper tier of coronary artery calcium (CAC)
(>1,000), constituting <5% of the study population.
Importantly, lower CAC in their study was associ-
ated with a risk of clinical events comparable to
other studies at the same level of CAC.
The studies by Puchner et al. (2) and Criqui et al. (3)
(Table 1) are particularly interesting in that they
provide insight into the interplay between various
prognostic factors in coronary artery disease
(CAD): plaque burden and plaque vulnerability.
Evaluating patients with chest pain using coronary
computed tomography angiography (CTA), Puchner
et al. (2) observed that high-risk plaque (deﬁned as
at least 1 of the following: positive remodeling,
plaque with low Hounsﬁeld units [<30], napkin-
ring sign, spotty calcium) was predictive of acute
coronary syndromes after adjustment for plaque
burden (any coronary artery with a $50% or $70%
stenosis). Criqui et al. (3) found that CV risk was
inversely proportional to CAC density (i.e., vulner-
able plaque features) at any level of CAC volume
(i.e., plaque burden). These studies demonstrate
the incremental prognostic value of characterizing
features of individual plaque vulnerability in theVulnerable Plaque Features
First Author
(Ref. #) Population Events
9.36 for
R ¼ 5.78 for
h p < 0.0001)
Puchner et al. (2) N ¼ 472 patients
undergoing CTA
for chest evaluation
ACS*: OR ¼ 8.9 for
“high-risk” plaque
(p ¼ 0.006)
2.38 for death
0.014) and
ivessel CAD
Stone et al. (5) N ¼ 697 with ACS
undergoing
PCI þ IVUS
MACE: HR ¼ 3.35 for
VH-TCFA (p < 0.001)
and HR ¼ 5.03 PB >70%
(p < 0.001)
increase
0.001)
HR ¼ 0.71 per increase in
CAC density (p < 0.001)
.
ery disease; CTA ¼ coronary computed tomography angiography; HR ¼ hazard ratio; IVUS¼ intravascular ultrasound;
atio; PB ¼ plaque burden; PCI ¼ percutaneous coronary intervention; RR ¼ risk ratio; TCFA ¼ thin-cap ﬁbroatheroma;
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758context of overall plaque burden in CV risk
prediction.
2. Intravascular ultrasound (IVUS) has been the
predominant invasive imaging modality used to
ascertain plaque features. The spatial resolution
of IVUS (w150 mm) is insufﬁcient for the diagnosis
of pathological thin-cap ﬁbroatheroma (TCFA;
ﬁbrous cap of 65 to 80 mm). Therefore, the limited
predictive ability of IVUS to identify TFCAs may
have contributed to imprecision in the character-
ization of lesion morphological changes over time.
Virtual histology and integrated backscatter IVUS
techniques have been developed to provide addi-
tional insight into individual plaque risk stratiﬁca-
tion by providing information about the spatial
distribution of various plaque tissue types (i.e.,
lipid, ﬁbrous, calciﬁc, etc.). Unfortunately, the
spatial resolution of backscatter-based IVUS tech-
niques remains limited, and the ability to accu-
rately distinguish various plaque tissues when
compared with real histology is questionable.
3. Most plaque ruptures are subclinical but these
events may be a principal mechanism underlying
plaque progression and, ultimately, the develop-
ment of plaque burden. Disregarding rupture-
prone plaque risks ignoring the pathophysiolog-
ical substrate for plaque progression, and ulti-
mately increases in plaque burden.
In conclusion, with the existing, although imper-
fect, evidence on vulnerable plaque from various
clinical studies, there is ample space for debating the
predictive value of vulnerable plaque identiﬁcation.
However, promoting the concept of the vulnerable
plaque as a myth may hinder further research capable
of obtaining novel insights into the transformation of
subclinical plaque rupture into manifest athero-
thrombosis, and limiting the accumulation of knowl-
edge that may shed light on mechanisms of plaque
progression. In the absence of evidence, we should
not assume evidence of absence in the role of high-
risk plaque in the genesis of atherothrombotic events.*Mazen S. Albaghdadi, MD, MS
Evan D. Muse, MD, PhD
*Division of Cardiology
Northwestern University
676 North St. Clair Street, Suite 600
Chicago, Illinois 60611
E-mail: m-albaghdadi@md.northwestern.edu
http://dx.doi.org/10.1016/j.jacc.2015.05.071
Please note: The authors have reported that they have no relationships relevant
to the contents of this paper to disclose. Peter Libby, MD, served as Guest Editor
for this paper.R EF E RENCE S
1. Budoff MJ, Shaw LJ, Liu ST, et al. Long-term prognosis associated with
coronary calciﬁcation: observations from a registry of 25,253 patients. J Am
Coll Cardiol 2007;49:1860–70.
2. Puchner SB, Liu T, Mayrhofer T, et al. High-risk plaque detected on coronary
CT angiography predicts acute coronary syndromes independent of signiﬁcant
stenosis in acute chest pain: results from the ROMICAT-II trial. J Am Coll
Cardiol 2014;64:684–92.
3. Criqui MH, Denenberg JO, Ix JH, et al. Calcium density of coronary artery
plaque and risk of incident cardiovascular events. JAMA 2014;311:271–8.
4. Cho I, Chang HJ, Sung JM, et al. Coronary computed tomographic angi-
ography and risk of all-cause mortality and nonfatal myocardial infarction in
subjects without chest pain syndrome from the CONFIRM registry (coronary
CT angiography evaluation for clinical outcomes: an international multicenter
registry). Circulation 2012;126:304–13.
5. Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study
of coronary atherosclerosis. N Engl J Med 2011;364:226–35.REPLY: Vulnerable Plaque
Absence of Evidence or Evidence of AbsenceWe thank Drs. Albaghdadi and Muse for extending
our discussion on the merit of detecting “vulnerable
plaques” by imaging. We agree with Albaghdadi and
Muse that we should not neglect a potential role of
individual plaque imaging in our risk assessment of
patients. As we discussed in our article, identifying
certain plaque characteristics may improve our ac-
curacy of risk prediction. Our intent was to empha-
size, however, that there is overwhelming evidence—
using various tools of assessment—in regard to the
strong relationship between the burden of athero-
sclerotic disease and risk of myocardial infarction and
death (1) compared with the much weaker data on
“vulnerable plaques” in this context. Indeed, none of
the papers listed by Albaghdadi and Muse in support
of “vulnerable plaque” risk prediction adjusted for
plaque burden: Puchner et al. (2) merely adjusted for
stenosis severity. Furthermore, major adverse car-
diovascular events in the study by Stone et al. (3) —as
discussed in our paper—are composed almost exclu-
sively of “soft” events, which should not be compared
with predicting death as is the case with most of the
studies listed for plaque burden. Current evidence
suggests the atherosclerotic plaque volume is the
predominant factor for determining risk of myocar-
dial infarction and death, whereas speciﬁc plaque
characteristics may have a modifying effect. It is
unclear at present which individual plaque features
are most useful for this purpose and whether such
assessment is of clinical value. Furthermore, the
“vulnerable” characteristics of a given plaque should
not be seen out of context of the patient’s speciﬁc
milieu. The fate of a plaque rupture largely depends
